HBsAg Rapid Quantitative Test

HBsAg is the surface antigen of the hepatitis B virus (HBV). It indicates current hepatitis B infection. Biotime HBsAg Rapid Quantitative Test kit can detect the specimen of serum and plasma.

HCV Rapid Quantitative Test

Hepatitis C is a liver disease caused by the hepatitis C virus (HCV): the virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis C is a major cause of liver cancer.

cTnI Rapid Quantitative Test

cTnI is a myocardial marker with high specificity and good sensitivity. The Biotime cTnI test kit has a wide detection range and high accuracy.

SAA Rapid Quantitative Test

Serum amyloid A (SAA) is a major acute phase protein in human beings, and dogs. The level of SAA proteins in blood increases within just a few hours following the onset of various inflammatory stimuli. These include infection, trauma and surgery

BIOT-YG-I FIA Analyzer (Fluorescence Immunoassay Analyzer)

BIOT-YG-I is a fluorescence immunoassay system with single channel that measures the quantitative concentration of a targeted analyte in human blood and urine.

HLC-100 Fully Automated HbA1c Analyzer

Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

BNP Rapid Quantitative Test (Chemiluminescence Immunoassay)

BNP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Brain natriuretic peptide (BNP) concentration in human plasma that contains EDTA anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

Ferritin Rapid Quantitative Test (Chemiluminescence Immunoassay)

Ferritin Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Ferritin concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of malignant tumor or inflammation.

Specimen Types	Plasma/Serum
Specimen Capacity	40μL
Reaction Time	10 min
Sample Capacity	80μL
Detection Range	0.5-250 IU/mL

Fluorescence Immunoassay

Infectious Disease Marker

HBsAg Rapid Quantitative Test